Literature DB >> 10343326

N-Methyl-D-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against beta-amyloid neurotoxicity.

T Harkany1, J Mulder, M Sasvári, I Abrahám, C Kónya, M Zarándi, B Penke, P G Luiten, C Nyakas.   

Abstract

Previous experimental data indicate the involvement of Ca(2+)-related excitotoxic processes, possibly mediated by N-Methyl-D-Aspartate (NMDA) receptors, in beta-amyloid (beta A) neurotoxicity. On the other hand, other lines of evidence support the view that free radical generation is a critical step in the beta A-induced neurodegenerative cascade. In the present study, therefore, a neuroprotective strategy was applied to explore the contributions of each of these pathways in beta A toxicity. beta A(1-42) was injected into the magnocellular nucleus basalis of rats, while neuroprotection was achieved by either single or combined administration of the NMDA receptor antagonist MK-801 (2.5 mg/kg) and/or a vitamin E and C complex (150 mg/kg). The degree of neurodegeneration was determined by testing the animals in consecutive series of behavioral tasks, including elevated plus maze, passive avoidance learning, small open-field and open-field paradigms, followed by acetylcholinesterase (AChE), choline-acetyltransferase (ChAT), and superoxide dismutase (SOD) biochemistry. beta A injected in the nucleus basalis elicited significant anxiety in the elevated plus maze, derangement of passive avoidance learning, and altered spontaneous behaviors in both open-field tasks. A significant decrease in both AChE and ChAT accompanied by a similar decrement of MnSOD, but not of Cu/ZnSOD provided neurochemical substrates for the behavioral changes. Each of the single drug administrations protected against the neurotoxic events, whereas the combined treatment failed to ameliorate beta A toxicity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10343326     DOI: 10.1006/nbdi.1998.0230

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  11 in total

Review 1.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

2.  Studies of the effects of fragment (25-35) of beta-amyloid peptide on the behavior of rats in a radial maze.

Authors:  M Yu Stepanichev; Yu V Moiseeva; N A Lazareva; N V Gulyaeva
Journal:  Neurosci Behav Physiol       Date:  2005-06

Review 3.  Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.

Authors:  Reinhard Schliebs
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

4.  Simultaneous release of glutamate and acetylcholine from single magnocellular "cholinergic" basal forebrain neurons.

Authors:  Timothy G J Allen; Fe C Abogadie; David A Brown
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

5.  The modulatory role of phloretin in Aβ25-35 induced sporadic Alzheimer's disease in rat model.

Authors:  Priya J Ghumatkar; Sachin P Patil; Vaibhavi Peshattiwar; Tushara Vijaykumar; Vikas Dighe; Geeta Vanage; Sadhana Sathaye
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-28       Impact factor: 3.000

6.  Memantine protects cholinergic and glutamatergic septal neurons from Aβ1-40-induced toxicity.

Authors:  L V Colom; M T Castaneda; D Aleman; A Touhami
Journal:  Neurosci Lett       Date:  2013-02-28       Impact factor: 3.046

7.  Schizandrin, an antioxidant lignan from Schisandra chinensis, ameliorates Aβ1-42-induced memory impairment in mice.

Authors:  Di Hu; Yunfeng Cao; Rongrong He; Na Han; Zhihui Liu; Lijing Miao; Jun Yin
Journal:  Oxid Med Cell Longev       Date:  2012-07-04       Impact factor: 6.543

Review 8.  GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease.

Authors:  Mauricio O Nava-Mesa; Lydia Jiménez-Díaz; Javier Yajeya; Juan D Navarro-Lopez
Journal:  Front Cell Neurosci       Date:  2014-06-25       Impact factor: 5.505

9.  Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert.

Authors:  Masahiro Tabuchi; Keita Mizuno; Kazushige Mizoguchi; Tomohisa Hattori; Yoshio Kase
Journal:  Front Pharmacol       Date:  2017-04-26       Impact factor: 5.810

10.  Comparative Effects of Alpha- and Gamma-Tocopherol on Mitochondrial Functions in Alzheimer's Disease In Vitro Model.

Authors:  Aslina Pahrudin Arrozi; Siti Nur Syazwani Shukri; Wan Zurinah Wan Ngah; Yasmin Anum Mohd Yusof; Mohd Hanafi Ahmad Damanhuri; Faizul Jaafar; Suzana Makpol
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.